Article: Carbon 11 labeling of the psychoactive drug o-methyl-bufotenine and its distribution in the animal organism

A methylated derivative of serotonin, O-methyl-bufotenine has been labeled with 11C on the two methyl groups of the amine function. In order to avoid the cyclization which occurs during the Eschweiler-Clarke synthesis, we adopted a milder methylation procedure, based on Borch's method using [11C]formaldehyde and sodium cyanoborohydride. Several tens of millicuries of injectable product could be obtained in 50 min in a perfectly pure state and having a specific radioactivity of 50 to 100 mCi/mumol. The distribution study of O-methyl-bufotenine in the mouse and rabbit showed an accumulation of significant quantities of the compound in the brain, kidneys, lungs and liver. The study of the rapid kinetics of this hallucinogenic molecule is compatible with labeling by 11C, having a period of 20 min. The use of O-methyl-[11C]bufotenine to detect serotonin receptors in vivo in mental diseases, is considered.

Citing Articles

A narrative synthesis of research with 5-MeO-DMT.

Ermakova A, Dunbar F, Rucker J, Johnson M J Psychopharmacol. 2021; 36(3):273-294.

PMID: 34666554 PMC: 8902691. DOI: 10.1177/02698811211050543.

Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Shen H, Jiang X, Winter J, Yu A Curr Drug Metab. 2010; 11(8):659-66.

PMID: 20942780 PMC: 3028383. DOI: 10.2174/138920010794233495.

A simple, rapid method for the preparation of [11C]formaldehyde.

Hooker J, Schonberger M, Schieferstein H, Fowler J Angew Chem Int Ed Engl. 2008; 47(32):5989-92.

PMID: 18604787 PMC: 2522306. DOI: 10.1002/anie.200800991.

In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine.

Yanai K, Ido T, Ishiwata K, Hatazawa J, Takahashi T, Iwata R Eur J Nucl Med. 1986; 12(3):141-6.

PMID: 3489620 DOI: 10.1007/BF00276707.

The physical performances of a single slice positron tomographic system and preliminary results in a clinical environment.

Soussaline F, Todd-Pokropek A, Plummer D, Comar D, Loch C, Houle S Eur J Nucl Med. 1979; 4(4):237-49.

PMID: 315311 DOI: 10.1007/BF00304879.

References

1.

Ahlborg U, Holmstedt B, Lindgren J . Fate and metabolism of some hallucinogenic indolealkylamines. Adv Pharmacol (1962). 1968; 6(Pt B):213-29. DOI: 10.1016/s1054-3589(08)60320-8. View

2.

Matthysse S, Lipinski J . Biochemical aspects of schizophrenia. Annu Rev Med. 1975; 26:551-65. DOI: 10.1146/annurev.me.26.020175.003003. View

3.

Banerjee S, Snyder S . N-methyltetrahydrofolic acid: the physiological methyl donor in indoleamine N- and O-methylation. Adv Biochem Psychopharmacol. 1974; 11(0):85-93. View

4.

Marazano C, Maziere M, Berger G, Comar D . Synthesis of methyl iodide-11 C and formaldehyde-11 C. Int J Appl Radiat Isot. 1977; 28(1-2):49-52. DOI: 10.1016/0020-708x(77)90159-4. View

5.

Sanders E, BUSH M . Distribution, metabolism and excretion of bufotenine in the rat with preliminary studies of its O-methyl derivative. J Pharmacol Exp Ther. 1967; 158(2):340-52. View

Carbon 11 Labeling of the Psychoactive Drug O-methyl-bufotenine and Its Distribution in the Animal Organism